Home » Authors » Kim Coghill

Articles by Kim Coghill

Amylin Sends Symlin Amendment To FDA, Seeks $150M In Notes

June 18, 2003

Biomira, Merck KGaA Report Failed Theratope Phase III Trial

June 18, 2003

Celltech, BMS Stop Development Of NSCLC Product After Phase II

June 17, 2003

Celltech, BMS Stop Development Of NSCLC Product After Phase II

June 17, 2003

Bush Plan On Generics Set To Go Into Effect In August

June 16, 2003

Bush Plan On Generics Set To Go Into Effect In August

June 16, 2003

Maxim Gets Back On Track After Reporting Positive Ceplene Data

June 13, 2003

Onyx Cuts Staff Further, Shifts Entire Focus To Bayer Program

June 13, 2003

Onyx Cuts Staff Further, Shifts Entire Focus To Bayer Program

June 13, 2003

Maxim Gets Back On Track After Reporting Positive Ceplene Data

June 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...